Publication – Clinical Validation Of A Novel Automated Cell‐Free DNA Screening Assay For Trisomies 21, 13, And 18 In Maternal Plasma

Learn how Cerba Research helps to evaluate the clinical performance of a new automated cell‐free (cf)DNA assay in maternal plasma screening for trisomies 21, 18, and 13, and to determine fetal sex.